Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma

Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma

Not available.

Saved in:

Bibliographic Details
Main Authors:	Julia Wendler, Richard I. Lewis, Alexandra Kutilina, Markus Knott, Lisa Kristina Isbell, Elke Valk, Peter Borchmann, Jan-Michel Heger, Gerald Illerhaus, Elisabeth Schorb
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2025-01-01
Series:	Haematologica
Online Access:	https://haematologica.org/article/view/11907
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Study of Teratogenic and Histological effects of treatment with Methotrexate and Rituximab in Swiss White Mice
by: Wajdi Sabeh Sadek, et al.
Published: (2023-02-01)

Prospective phase II trial of first-line rituximab, methotrexate, and orelabrutinib (R-MO) in primary central nervous system lymphoma
by: Lixia Sheng, et al.
Published: (2025-04-01)

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder of the Central Nervous System with High-Dose Methotrexate
by: Clare J. Twist, et al.
Published: (2013-01-01)

THE TREATMENT OF MULTIPLE MYELOMA PATIENTS NOT ELIGIBLE FOR ASCT
by: Anuj Mahindra, et al.
Published: (2010-05-01)

A response of rituximab plus lenalidomide therapy in patients with post-transplant lymphoproliferative disease and methotrexate-related lymphoproliferative disorder in the central nervous system: a case report
by: Hanguo Guo, et al.
Published: (2025-05-01)

Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
by: Ruben Fernandez, et al.
Published: (2014-02-01)

Effectiveness of rituximab in the treatment of patients with pemphigus vulgarus
by: Arfenya E. Karamova, et al.
Published: (2024-11-01)

Methotrexate in the treatment of rheumatic disease
by: Marina Zinovyevna Kanevskaya, et al.
Published: (2013-12-01)

COMBINED MODALITY TREATMENT INCLUDING METHOTREXATE-BASED CHEMOTHERAPY FOR PRIMARY CEREBRAL NERVOUS SYSTEM LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE
by: Giuseppina Massini, et al.
Published: (2009-11-01)

Methotrexate in the treatment of juvenile chronic arthritis
by: N N Rodionovskaya, et al.
Published: (2003-04-01)

Methotrexate dosage in the treatment of rheumatoid arthritis
by: Yuri Vladimirovich Muravyev
Published: (2013-11-01)

Methotrexate for the Treatment of Thyroid Eye Disease
by: Diego Strianese, et al.
Published: (2014-01-01)

Usefulness of methotrexate in the treatment of rheumatoid arthritis
by: Enrique Rodríguez Reyes, et al.
Published: (2024-11-01)

Physical activity in non-frail and frail older adults.
by: F Marijke Jansen, et al.
Published: (2015-01-01)

Applications of rituximab in the treatment of renal diseases
by: Liu Zi, et al.
Published: (2021-01-01)

METHOTREXATE IN THE TREATMENT OF COXITIS IN EARLY SPONDYLOARTHRITIS: ARE THERE PROSPECTS?
by: T. V. Dubinina, et al.
Published: (2015-09-01)

Comparative study of Methotrexate and Cyclosporine in the treatment of Psoriasis
by: D Karn, et al.
Published: (2012-01-01)

Comparative study of Methotrexate and Cyclosporine in the treatment of Psoriasis
by: D Karn, et al.
Published: (2012-01-01)

Use of methotrexate in the treatment of psoriasis and psoriatic arthritis
by: Tatiana Viktorovna Korotaeva, et al.
Published: (2013-06-01)

Methotrexate in the treatment of rheumatoid arthritis and psoriatic arthritis
by: N. V. Chichasova, et al.
Published: (2021-06-01)

Current practice of methotrexate treatment for rheumatoid arthritis
by: Yuri Vladimirovich Muravyev, et al.
Published: (2012-08-01)

Enhancing ovarian cancer treatment: Synergistic effects of methotrexate (Methotrexate)- and quercetin-loaded chitosan nanoparticles
by: Hamed Dadashi, et al.
Published: (2024-12-01)

Immune and targeted therapy for cancer: time to rethink restrictions for the treatment of the elderly and frail
by: Juliana Rodrigues Beal, et al.
Published: (2021-10-01)

CHANGES OF BONE MINERAL DENSITY DURING FOUR-YEAR RITUXIMAB AND METHOTREXATE THERAPY IN POSTMENOPAUSAL WOMEN WITH RHEUMATOID ARTHRITIS
by: T. A. Raskina, et al.
Published: (2016-12-01)

Safety and tolerability of rituximab in the treatment of systemic sclerosis
by: L. A. Garzanova, et al.
Published: (2023-04-01)

Rituximab in the treatment of systemic sclerosis. Literature review
by: L. A. Garzanova
Published: (2023-08-01)

Experience of polymyositis and antisynthetase syndrome treatment with rituximab
by: S. G. Palshina, et al.
Published: (2015-02-01)

Population pharmacokinetics of high-dose methotrexate in patients with primary central nervous system lymphoma
by: Shifeng Wei, et al.
Published: (2025-05-01)

Rituximab Monotherapy versus Rituximab and Bortezomib Combination Therapy for Treatment of Non-paraneoplastic Autoimmune Retinopathy
by: Arash Maleki, et al.
Published: (2022-11-01)

Gait parameters and daily physical activity for distinguishing pre-frail, frail, and non-frail older adults: A scoping review
by: Xin Zhang, et al.
Published: (2025-07-01)

Insulin Predicts Methotrexate Response by Affecting the Transcription of Methotrexate Target Genes in the Treatment-Naive Rheumatoid Arthritis
by: Victoria M. E. Lundgren, et al.
Published: (2025-06-01)

EFFICACY AND SAFETY OF COMBINATION TREATMENT WITH ABATACEPT AND METHOTREXATE AND MONOTHERAPY WITH METHOTREXATE IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
by: V. A. Kel'tsev, et al.
Published: (2012-11-01)

Physical Exercise Intervention Characteristics and Outcomes in Frail and Pre-Frail Older Adults
by: María Caicedo-Pareja, et al.
Published: (2024-12-01)

COMPARATIVE EFFICACY OF RITUXIMAB AND METHOTREXATE MONOTHERAPY IN STANDARD DOSES IN PATIENTS WITH SEVERE SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (PRELIMINARY RESULTS)
by: E. I. Alexeeva, et al.
Published: (2012-01-01)

Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies
by: Maxime Teisseyre, et al.
Published: (2025-03-01)

METHOTREXATE — «GOLD STANDARD» OF JUVENILE RHEUMATOID ARTHRITIS TREATMENT
by: Ye. I. Alekseyeva, et al.
Published: (2011-01-01)

The importance of good adherence to methotrexate in the treatment of rheumatoid arthritis
by: Ćeranić Jelena, et al.
Published: (2025-01-01)

Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
by: David Jayne, et al.
Published: (2019-06-01)

EXPERIENCE OF RITUXIMAB TREATMENT IN A PATIENT WITH JUVENILE SCLERODERMA
by: E. I. Alexeeva, et al.
Published: (2012-05-01)

Rituximab-Based Treatment, HCV Replication, and Hepatic Flares
by: Evangelista Sagnelli, et al.
Published: (2012-01-01)